LFGIX
Price
$34.64
Change
-$0.31 (-0.89%)
Updated
May 9 closing price
Net Assets
94.86M
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

LFGIX vs RGAHX

Header iconLFGIX vs RGAHX Comparison
Open Charts LFGIX vs RGAHXBanner chart's image
Lord Abbett Focused Growth I
Price$34.64
Change-$0.31 (-0.89%)
VolumeN/A
Net Assets94.86M
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
LFGIX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LFGIX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFGIX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. LFGIX (94.9M). RGAHX pays higher dividends than LFGIX: RGAHX (0.54) vs LFGIX (0.00). LFGIX was incepted earlier than RGAHX: LFGIX (6 years) vs RGAHX (9 years). LFGIX (1.20) is less costly to investors than RGAHX (0.44). LFGIX is a more actively managed with annual turnover of: 122.00 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than LFGIX: RGAHX (250) vs LFGIX (1000000). LFGIX annual gain was more profitable for investors over the last year : 24.38 vs. RGAHX (3.25). LFGIX return over 5 years is better than : 73.98 vs. RGAHX (44.87).
LFGIXRGAHXLFGIX / RGAHX
Total Expense Ratio0.800.44182%
Annual Report Gross Expense Ratio1.200.44273%
Fund Existence6 years9 years-
Gain YTD-6.150-2.478248%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets94.9M285B0%
Annual Yield % from dividends0.000.54-
Returns for 1 year24.383.25750%
Returns for 3 years66.8633.40200%
Returns for 5 years73.9844.87165%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics